Genetic testing for von Willebrand disease: the case against.
Favaloro
E J
EJ
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW, Australia. emmanuel.favaloro@swahs.health.nsw.gov.au
D003362:Cost-Benefit Analysis; D004252:DNA Mutational Analysis / Q000191:economics / Q000592:standards; D005188:False Negative Reactions; D005189:False Positive Reactions; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000191:economics / Q000379:methods* / Q000592:standards; D006801:Humans; D007349:Insurance, Health, Reimbursement; D009154:Mutation; D010641:Phenotype; D011237:Predictive Value of Tests; D011786:Quality Control; D015203:Reproducibility of Results; D014842:von Willebrand Diseases / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D014841:von Willebrand Factor / Q000235:genetics* / Q000378:metabolism
D014841:von Willebrand Factor